Back
Simmons First National Corp. Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
56
SFNC
Simmons First National Corp.
Last Price:
$19.65
Seasonality Move:
-1.1%
Sell
43
CRSP
CRISPR Therapeutics AG
Last Price:
$56.56
Seasonality Move:
16.15%
Buy
56
Simmons First National Corp. (SFNC)
is a Buy
Is Simmons First National Corp. a Buy, Sell or Hold?
-
The current Simmons First National Corp. [SFNC] share price is $19.57. The Score for SFNC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
SFNC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $55.97. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SFNC Stock Price Chart
What is Simmons First National Corp.'s stock price today?
-
The Simmons First National Corp. share price today is $19.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFNC is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $55.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight selling pressure.
SFNC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 64.75 | Buy |
| Chaikin Money Flow: | 859866 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.8 - 19.22) | Buy |
| Bollinger Bands (100): | (18.07 - 20.17) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 48.84 | Sell |
| Chaikin Money Flow: | -466021 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.56 - 56.88) | Buy |
| Bollinger Bands (100): | (52.61 - 65.53) | Sell |
SFNC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.27 | Buy |
| 20-day SMA: | 18.68 | Buy |
| 50-day SMA: | 18.32 | Buy |
| 200-day SMA: | 19.24 | Buy |
| 8-day EMA: | 19.3 | Buy |
| 20-day EMA: | 18.86 | Buy |
| 50-day EMA: | 18.69 | Buy |
| 200-day EMA: | 19.39 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.98 | Sell |
| 20-day SMA: | 54.45 | Buy |
| 50-day SMA: | 60.1 | Sell |
| 200-day SMA: | 50.92 | Buy |
| 8-day EMA: | 56.41 | Sell |
| 20-day EMA: | 56 | Sell |
| 50-day EMA: | 56.51 | Sell |
| 200-day EMA: | 37.03 | Buy |
Simmons First National Corp. Earnings Growth & SFNC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.26 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Simmons First National Corp. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||